[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Safety and Immunogenicity of FluzoneĀ® Quadrivalent Vaccine
Administered to Healthy Children 6 to < 36 Months of Age

What is the purpose of the study? (in Layman's terms, please describe the study)

The main purpose of conducting this research study is to see if a full dose (0.5-mL volume) of Fluzone Quadrivalent vaccine is as safe and offers as much protection against flu viruses as the half dose (0.25-mL volume) in children 6 through 35 months of age. Vaccine safety will be measured by watching for any possible reactions to the flu vaccine, including fever.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:

Study GRC88

Study Phase:

Phase IV

Patient Age Group:


Principal Investigator:

Leonard B Weiner

Who can I contact for more information?

Name: Maureen J Butler
Phone: 315-464-9441
Email: butlermj@upstate.edu

Return to Previous Page || Search Again